Michelle represents life sciences clients in patent litigation disputes across a wide range of pharmaceutical technologies, including biologics and small molecules. She is experienced in Hatch-Waxman litigation as well as traditional patent infringement disputes spanning formulation, drug product and method of treatment claims. Michelle has represented clients in all stages of litigation, including claim construction, discovery, trial and appeal.
Michelle also counsels clients on patent strategy, IP portfolio evaluation and an assortment of regulatory matters.
Prior to joining Fenwick, Michelle was an associate at an Am Law 50 firm, where her practice focused on pharmaceutical, biotech and chemical patent litigation.
During law school, Michelle served as an intern for the U.S. Food and Drug Administration, U.S. Department of Labor, and U.S. Senate Committee on Health, Education, Labor and Pensions.